These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25795317)

  • 1. Synergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patients.
    Vourli S; Frantzeskaki F; Meletiadis J; Stournara L; Armaganidis A; Zerva L; Dimopoulos G
    Int J Antimicrob Agents; 2015 Jun; 45(6):670-1. PubMed ID: 25795317
    [No Abstract]   [Full Text] [Related]  

  • 2. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
    Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.
    Ceccarelli G; Oliva A; d'Ettorre G; D'Abramo A; Caresta E; Barbara CS; Mascellino MT; Papoff P; Moretti C; Vullo V; Visca P; Venditti M
    BMC Infect Dis; 2015 Sep; 15():393. PubMed ID: 26424078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
    J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model.
    Liu X; Zhao M; Chen Y; Bian X; Li Y; Shi J; Zhang J
    Int J Antimicrob Agents; 2016 Nov; 48(5):559-563. PubMed ID: 27670371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates.
    Hong DJ; Kim JO; Lee H; Yoon EJ; Jeong SH; Yong D; Lee K
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):184-9. PubMed ID: 27475960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model.
    Fan B; Guan J; Wang X; Cong Y
    PLoS One; 2016; 11(6):e0157757. PubMed ID: 27315107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy against extensively drug-resistant Acinetobacter baumannii in vitro by two old antibiotics: colistin and chloramphenicol.
    Wei WJ; Yang HF
    Int J Antimicrob Agents; 2017 Mar; 49(3):321-326. PubMed ID: 28167347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.
    Inchai J; Liwsrisakun C; Theerakittikul T; Chaiwarith R; Khositsakulchai W; Pothirat C
    J Infect Chemother; 2015 Aug; 21(8):570-4. PubMed ID: 26026660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rate of colistin dependence in Acinetobacter baumannii.
    Hong YK; Lee JY; Wi YM; Ko KS
    J Antimicrob Chemother; 2016 Aug; 71(8):2346-8. PubMed ID: 27076109
    [No Abstract]   [Full Text] [Related]  

  • 11. A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii.
    Marie MA; Krishnappa LG; Alzahrani AJ; Mubaraki MA; Alyousef AA
    Bosn J Basic Med Sci; 2015 Oct; 15(4):24-9. PubMed ID: 26614848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential roles of antimicrobials in the acquisition of drug resistance through activation of the SOS response in Acinetobacter baumannii.
    Jara LM; Cortés P; Bou G; Barbé J; Aranda J
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4318-20. PubMed ID: 25896685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii.
    Temocin F; Erdinc FS; Tulek N; Demirelli M; Ertem G; Kinikli S; Koksal E
    Braz J Microbiol; 2015; 46(4):1119-24. PubMed ID: 26691470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postantibiotic effect of colistin alone and combined with vancomycin or meropenem against Acinetobacter spp. with well defined resistance mechanisms.
    Bedenić B; Beader N; Godič-Torkar K; Prahin E; Mihaljević L; Ćačić M; Vraneš J
    J Chemother; 2016 Oct; 28(5):375-82. PubMed ID: 26319682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Colistin and Sulbactam Combination Effectivity in Multi Drug Resistant Acinetobacter baumannii Strains with Diagonal Gradient Strip Test Method.
    Hatipoglu H; Kilbas I; Kilic U; Yilmaz K; Koroglu M; Altindis M
    Clin Lab; 2018 Oct; 64(11):. PubMed ID: 30549991
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates.
    Piewngam P; Kiratisin P
    Int J Antimicrob Agents; 2014 Nov; 44(5):396-401. PubMed ID: 25442358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an
    Bian X; Liu X; Chen Y; Chen D; Li J; Zhang J
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Mechanisms of Colistin Resistance Among Pandrug-Resistant Isolates of Acinetobacter baumannii with High Case-Fatality Rate in Intensive Care Unit Patients.
    Haeili M; Kafshdouz M; Feizabadi MM
    Microb Drug Resist; 2018 Nov; 24(9):1271-1276. PubMed ID: 29590004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colistin-resistant Acinetobacter baumannii ventilator-associated pneumonia in a tertiary care hospital: an evolving threat.
    Gupta M; Lakhina K; Kamath A; Vandana KE; Mukhopadhyay C; Vidyasagar S; Varma M
    J Hosp Infect; 2016 Sep; 94(1):72-3. PubMed ID: 27238611
    [No Abstract]   [Full Text] [Related]  

  • 20. In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates.
    Nepka M; Perivolioti E; Kraniotaki E; Politi L; Tsakris A; Pournaras S
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6903-6906. PubMed ID: 27550356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.